Clinical Trial Update: Safety and Efficacy Study of Umbilical Cord Blood-Drived Mesenchymal Stem Cells to Promote Engraftment of Unrelated Hematopoietic Stem Cell Transplantation [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1/2 clinical trial evaluating umbilical cord blood-derived mesenchymal stem cells to promote engraftment in unrelated hematopoietic stem cell tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Umbilical Cord Blood-Derived Mesenchymal Stem Cells (mesenchymal stem cells)

Snippet

Sponsor: Medipost Co Ltd. | Conditions: Acute Leukemia | Phase 1, Phase 2 | Status: COMPLETED